Dr Reddy’s Q3 PAT rises 2% despite 16% jump in revenues
[ad_1] HYDERABAD: Despite posting record revenues, pharma major Dr Reddy’s Laboratories on Thursday reported a marginal 2% increase in consolidated profit after tax (PAT attributable to equity holders) at Rs 1414.3 crore as compared to Rs 1,379 crore in the corresponding quarter of last fiscal year.The company posted a 16% jump in revenues at nearly…